An international study finds a beneficial effect of pregnancy.
Past studies suggested that pregnancy has a protective effect and accumulative effect on the development of multiple sclerosis (MS), possibly through the anti-inflammatory effects of hormones. Investigators for this retrospective cohort study included 2557 women diagnosed with MS from four hospitals.
Before MS onset, 46% of the women had been pregnant and 43% had given birth. Women with prior pregnancies had a later onset of first MS symptoms than women who had never been pregnant (hazard ratio, 0.68; 95% confidence interval, 0.62-0.75). Pregnancy resulted in a median delay of 3.3 years to first MS symptoms. Additional pregnancies did not add to this effect.
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)